Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial-Reference-Cited by-同舟云学术

Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial

Published:2020-10 Issue:8 Volume:16 Page:634-644
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Takahashi Kuniaki,Chichareon Ply,Modolo Rodrigo,Kogame Norihiro,Chang Chun Chin,Tomaniak Mariusz,Moschovitis Aris,Curzen Nick,Haude Michael,Jung Werner,Holmvang Lene,Garg Scot,Tijssen Jan G.P.,Wykrzykowska Joanna J.,de Winter Robbert J.,Hamm Christian,Steg Philippe Gabriel,Stoll Hans-Peter,Onuma Yoshinobu,Valgimigli Marco,Vranckx Pascal,Windecker Stephan,Serruys Patrick W.

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCI;Reviews in Cardiovascular Medicine;2022-10-17

2. P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention;Journal of Cardiovascular Development and Disease;2022-10-06

3. P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention;Nature Reviews Cardiology;2022-06-13

4. ‘Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI’: a post hoc analysis of the randomized GLOBAL LEADERS trial;European Heart Journal. Acute Cardiovascular Care;2021-07-02

5. Impact of stent length and diameter on 10‐year mortality in the SYNTAXES trial;Catheterization and Cardiovascular Interventions;2021-05-05